Maia Wealth LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 81.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,114 shares of the healthcare conglomerate’s stock after acquiring an additional 3,186 shares during the quarter. Maia Wealth LLC’s holdings in UnitedHealth Group were worth $2,219,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Bayforest Capital Ltd raised its position in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the period. LFA Lugano Financial Advisors SA bought a new stake in UnitedHealth Group in the 2nd quarter worth approximately $25,000. Islay Capital Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at $31,000. Finally, Nova Wealth Management Inc. increased its position in UnitedHealth Group by 339.1% during the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock valued at $53,000 after acquiring an additional 78 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
Analyst Ratings Changes
UNH has been the topic of a number of research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sanford C. Bernstein boosted their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Jefferies Financial Group raised their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research report on Friday, October 17th. Finally, Morgan Stanley increased their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $397.12.
UnitedHealth Group Price Performance
NYSE:UNH opened at $326.23 on Wednesday. The company has a market capitalization of $295.51 billion, a P/E ratio of 17.03, a P/E/G ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83. The business’s 50-day moving average is $343.84 and its 200 day moving average is $315.01. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same period last year, the firm posted $7.15 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s payout ratio is presently 46.14%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Retail Stocks Investing, Explained
- History Says These are 3 Stocks to Buy for December
- What is the FTSE 100 index?
- Warner Bros. Sale Rumors Heat Up: What Investors Need to Know
- 3 Stocks to Consider Buying in October
- From Science Project to Solvent: WeRide’s 761% Revenue Surge
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
